Curi RMB Capital, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Curi RMB Capital, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2015$2,327,000
+4.9%
106,394
+15.9%
0.15%
+6.9%
Q2 2015$2,218,000
-3.1%
91,793
+0.3%
0.14%
+4.3%
Q1 2015$2,288,000
+26.9%
91,495
+5.8%
0.14%
+25.5%
Q4 2014$1,803,000
-13.7%
86,511
-10.0%
0.11%
-14.1%
Q3 2014$2,090,000
+13.6%
96,140
+21.2%
0.13%
+10.3%
Q2 2014$1,839,000
+1.0%
79,306
+3.4%
0.12%
-7.2%
Q1 2014$1,821,000
+8.1%
76,670
+4.5%
0.12%
+6.8%
Q4 2013$1,685,000
-30.7%
73,384
-28.8%
0.12%
-33.1%
Q3 2013$2,433,000
+11.5%
103,025
+6.4%
0.18%
+6.1%
Q2 2013$2,183,00096,8130.16%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders